Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $754.96M.
ENTERPRISE VALUE (EV)
$754.96M
Alumis Inc.
Market Cap
$839.96M
Enterprise Value (EV)
$754.96M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Alumis Inc. (ALMS) | $839.96M | $754.96M |
| QuidelOrtho Corporation (QDEL)vs › | $840.79M | $3.79B |
| Beta Bionics, Inc. (BBNX)vs › | $841.31M | $803.50M |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $838.46M | $786.34M |
| SpyGlass Pharma, Inc. Common Stock (SGP)vs › | $842.23M | $620.72M |
| Pacific Biosciences of California, Inc. (PACB)vs › | $849.50M | $1.49B |
| SI-BONE, Inc. (SIBN)vs › | $857.86M | $831.90M |
| SL Science Holding Ltd (SLBT)vs › | $860.77M | $859.72M |
| Ardelyx, Inc. (ARDX)vs › | $816.73M | $975.73M |
| Jade Biosciences, Inc. (JBIO)vs › | $813.73M | $707.10M |
Market Cap
$839.96M
Total Debt
$4.67M
Cash
$89.67M
Enterprise Value
$754.96M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
